These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25533045)

  • 41. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1.
    Wang HH; Zhou HY; Chen CC; Zhang XL; Cheng G
    Acta Pharmacol Sin; 2007 Aug; 28(8):1175-80. PubMed ID: 17640480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation.
    Lv J; Wang X; Liu SY; Liang PF; Feng M; Zhang LL; Xu AP
    Pathol Biol (Paris); 2015 Dec; 63(6):236-42. PubMed ID: 26343046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury.
    Mulder GM; Nijboer WN; Seelen MA; Sandovici M; Bos EM; Melenhorst WB; Trzpis M; Kloosterhuis NJ; Visser L; Henning RH; Leuvenink HG; Ploeg RJ; Sunnarborg SW; van Goor H
    J Pathol; 2010 Jun; 221(2):183-92. PubMed ID: 20225242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AGS3-dependent trans-Golgi network membrane trafficking is essential for compaction in mouse embryos.
    Nie ZW; Niu YJ; Zhou W; Zhou DJ; Kim JY; Cui XS
    J Cell Sci; 2020 Dec; 133(23):. PubMed ID: 33148610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad.
    Blumer JB; Lanier SM
    Mol Pharmacol; 2014 Mar; 85(3):388-96. PubMed ID: 24302560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity.
    Hama T; Nagesh PK; Chowdhury P; Moore BM; Yallapu MM; Regner KR; Park F
    JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34806647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.
    Vural A; Lanier SM
    J Cell Sci; 2020 Sep; 133(17):. PubMed ID: 32737219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the "kidney governing bone" theory.
    Yao B; Liu J; Zhang M; Leng X; Zhao D
    J Orthop Surg Res; 2020 Apr; 15(1):146. PubMed ID: 32295616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney disease.
    Keri KC; Regner KR; Dall AT; Park F
    BMC Res Notes; 2018 Jun; 11(1):359. PubMed ID: 29880041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.
    Pressly JD; Mustafa SM; Adibi AH; Alghamdi S; Pandey P; Roy KK; Doerksen RJ; Moore BM; Park F
    J Pharmacol Exp Ther; 2018 Feb; 364(2):287-299. PubMed ID: 29187590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury.
    Pressly JD; Hama T; Brien SO; Regner KR; Park F
    Sci Rep; 2017 Mar; 7():43196. PubMed ID: 28256593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterotrimeric G protein signaling in polycystic kidney disease.
    Hama T; Park F
    Physiol Genomics; 2016 Jul; 48(7):429-45. PubMed ID: 27199453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 Activation.
    Rasmussen SA; Kwon M; Pressly JD; Blumer JB; Regner KR; Park F
    J Mol Signal; 2015 Nov; 10():6. PubMed ID: 27096004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accessory proteins for heterotrimeric G-proteins in the kidney.
    Park F
    Front Physiol; 2015; 6():219. PubMed ID: 26300785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activators of G protein signaling in the kidney.
    Park F
    J Pharmacol Exp Ther; 2015 May; 353(2):235-45. PubMed ID: 25628392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization and expression profile of Group I and II Activators of G-protein Signaling in the kidney.
    Lenarczyk M; Pressly JD; Arnett J; Regner KR; Park F
    J Mol Histol; 2015 Apr; 46(2):123-36. PubMed ID: 25533045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents.
    Regner KR; Nozu K; Lanier SM; Blumer JB; Avner ED; Sweeney WE; Park F
    FASEB J; 2011 Jun; 25(6):1844-55. PubMed ID: 21343176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury.
    Zahedi K; Wang Z; Barone S; Prada AE; Kelly CN; Casero RA; Yokota N; Porter CW; Rabb H; Soleimani M
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1046-55. PubMed ID: 12554636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activator of G protein signaling 3 is a guanine dissociation inhibitor for Galpha i subunits.
    De Vries L; Fischer T; Tronchère H; Brothers GM; Strockbine B; Siderovski DP; Farquhar MG
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14364-9. PubMed ID: 11121039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins.
    Lanier SM
    Biol Cell; 2004 Jun; 96(5):369-72. PubMed ID: 15207906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.